‘Unlocking Success: Mastering your RWE Pregnancy Studies
Next session of the Free Live Online Webinar Series on RWE hosted by OXON
Date: Wednesday, 12 February 2025
Time: 5pm CEST | 11am EDT | 8am PST
Speaker: Prof. Helen Dolk
Professor of Epidemiology and Health Services Research at Ulster University.
Real-world evidence (RWE) plays a transformative role in enhancing the understanding of drug safety, efficacy, and outcomes during pregnancy. Pregnancy presents a unique set of challenges for researchers, such as ethical constraints on clinical trials, complex biological variables, and the need for large, diverse datasets. RWE helps overcome these hurdles by leveraging real-world data (RWD) to provide actionable insights
In just 60 minutes, gain a comprehensive understanding of the critical methodologies for studying drug exposure outcomes in pregnancy. Learn how to apply these approaches in real-world settings, whether in primary, secondary, or hybrid observational studies.
The content covers a review of the following topics:
– What makes pregnancy studies unique?
– Understanding the range of adverse pregnancy outcomes
– Study designs and innovative approaches
– The role of “pregnancy registries”
– Essential criteria for selecting data sources
– Addressing scientific and practical challenges
– Interactive Q&A session
About this Free Live Webinar Series on RWE and Healthcare hosted by OXON
Through this Free Live Webinar Series on Real-World Evidence (RWE) and Healthcare, OXON brings together renowned pharmacoepidemiologists and project managers with expertise in safety and outcomes research, as well as observational studies using databases. During these webinars, experts will share their knowledge and provide practical examples based on their experience with drugs and vaccines.
The series covers topics relevant to several countries, including the US, Italy, the UK, France, Germany, the Nordic countries, Spain, Japan, Taiwan, South Korea, and China. Specific sessions focus on multi-country field studies, multi-country database studies, pregnancy studies, post-authorization safety studies (PASS), and risk minimization effectiveness studies.
By attending these webinars, participants will gain valuable insights into healthcare systems and data sources from various countries, helping them enhance their expertise in real-world studies.